QS Batterymarch Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History

QS Batterymarch Financial Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$20.9M	Sell	57,996 -11,350	-16%	-$3.8M	0.55%	29
2014 Q2	$19.6M	Sell	69,346 -15,738	-18%	-$4.66M	0.5%	34
2014 Q1	$25.6M	Sell	85,084 -3,177	-4%	-$979K	0.53%	28
2013 Q4	$24.3M	Buy	88,261 +3,831	+5%	+$1.1M	0.51%	31
2013 Q3	$26.4M	Buy	84,430 +3,034	+4%	+$798K	0.57%	20
2013 Q2	$18.3M	Buy	+81,396	New	+$19M	0.35%	67

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

QS Batterymarch Financial Management's REGN Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Regeneron Pharmaceuticals (REGN) stake by 16% in Q3 2014, selling an estimated $3.8M and leaving 57,996 shares worth $20.9M. The position accounts for 0.55% of the portfolio, ranked #29.

QS Batterymarch Financial Management first reported a position in REGN in Q2 2013 and has held it in 6 quarters since. The position peaked at $26.4M in Q3 2013. 473 funds tracked by Wall St. Rank hold REGN as of Q3 2014.

QS Batterymarch Financial Management held 57,996 shares of Regeneron Pharmaceuticals worth $20.9M as of Q3 2014.
QS Batterymarch Financial Management sold 11,350 Regeneron Pharmaceuticals shares in Q3 2014, an estimated $3.8M.
Regeneron Pharmaceuticals made up 0.55% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #29 holding.
QS Batterymarch Financial Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
QS Batterymarch Financial Management's Regeneron Pharmaceuticals position peaked at $26.4M in Q3 2013.
473 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.